Metraipolis › archive › dc_c013b012e8bd

mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions — Europe PMC PMID:38140142

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38140142
DOI
10.3390/vaccines11121737
License (as archived)
solo-consultazione
Archived
2026-10-07T17:57:11.763Z
SHA-256 of the archived text
4377804f727e931667c43e1ed8199a05780b7dcfcfeb0aef6430057f99b65f4d
Stable URL of this page
https://metraipolis.com/documento/dc_c013b012e8bd

How to cite

mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions — Europe PMC PMID:38140142 — Europe PMC (en), https://europepmc.org/article/MED/38140142 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c013b012e8bd (Metraipolis archive dc_c013b012e8bd, sha256 4377804f727e931667c43e1ed8199a05780b7dcfcfeb0aef6430057f99b65f4d)
BibTeX
@misc{dcc013b012e8bd,
  title = {mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions — Europe PMC PMID:38140142},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38140142},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c013b012e8bd; sha256 4377804f727e931667c43e1ed8199a05780b7dcfcfeb0aef6430057f99b65f4d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38140142. Agents can read the archived copy with the MCP tool read_document.